Abstract
Bleomycin (BLM) is an antitumor antibiotic produced by a strain of Streptomyces verticillus (1). Clinically employed bleomycin (Blenoxane) is a mixture of 11 active components. Of these, bleomycin A2 (BLM A2) , 1(2), is the most abundant, accounting for 55-70% (w/w) of the mixture. Bleomycin is of value in the treatment of squamous cell carcinomas, lymphomas, and testicular carcinomas (3,4). The mechanism of action of bleomycin is not understood. Most of the early efforts as well as those in progress have focused on the interaction of bleomycin, most often bleomycin A2 , with DNA. The glycolpeptide is capable of 11 active components. Of these, bleomycin A2 (BLM A2 ) , 1(2), is the most abundant, accounting for 55-70% (w/w) of the mixture. Bleomycin is of value in the treatment of squamous cell carcinomas, lymphomas, and testicular carcimixture prevents DNA breakage. It is known that these metal ions complex to bleomycin and in so doing apparently inactivate the drug.
The online version of the original chapter can be found at http://dx.doi.org/10.1007/978-1-4612-6191-9_10
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
H. Umezawa, K. Maeda, T. Takeuchi, and Y. Akami, J. Antibiot, (Tokyo), Ser. A., 19, 200 (1969).
A new structure for bleomycin and related antibiotics was proposed by Drs. Umezawa and Takita during the symposium.
H. Umezawa, Biomedicine, 18, 459 (1973).
R.H. Blum, S.K. Carter, and K.A. Agre, Cancer, 31, 903 (1973).
L.F. Povirk, W. Wiibker, W. Kohnlein, and F. Hutchinson, Nucl. Acid Res.,4, 3573 (1977).
C.W. Haidle, Mol. Pharmacol., 7, 645 (1971).
C.W. Haidle, K.K. Weiss, and M.T. Kuo, Mol. Pharmacol., 8, 531 (1972).
M.T. Kuo and C.W. Haidle, Biochim. Biophys. Acta, 335, 109 (1974).
W.E.G. Müller, Z. Yamazaki, H.J. Breter, and R.K. Zahn, Eur. J. Biochem., 31, 518 (1972).
A. Kono, Y. Matsushima, M. Kojima, and T. Maeda, Chem. Pharm. Bull. (Tokyo), 25, 1725 (1977).
K. Nagai H. Yamaki H. Suzuki N. Tanaka and H. Umezawa Biochim. Biophys. Acta 179, 165 (1969).
E.A. Sausville, J. Peisach, and S.B. Horwitz, Biochem. Biophys. Res. Commun., 73, 814 (1976).
J.W. Lown and S. Sim, Biochem. Biophys. Res. Commun.,77, 1150 (1977).
I. Shirakawa, M. Azegami, S. Ishii, and H. Umezawa, J. Antibiot. (Tokyo), 24, 761 (1971).
M. Takeshita, A.P. Grollman, and S.B. Horwitz, Virology,69, 453 (1976).
K. Takahashi, O. Yoshioka, A. Matsuda, and H. Umezawa, J. Antibiot. (Tokyo), 30, 861 (1977).
H. Suzuki, K. Nagai, H. Yamaki, N. Tanaka, and H. Umezawa, J. Antibiot. (Tokyo), 21, 379 (1968).
T. Ichikawa, A. Matsuda, K. Miyamoto, M. Tsubosaki, T. Kaihara, K. Sakamoto, and H. Umezawa, J. Antibiot. (Tokyo), 20, 149 (1967).
M. Ishizuka, H. Takayama, T. Takeuchi, and H. Umezawa, J. Antibiot. (Tokyo),20, 15 (1967).
H. Umezawa, M. Ishizuka, K. Kimura, J. Iwanaga, and T. Takeuchi, J. Antibiot. (Tokyo), 21, 592 (1968).
J.C. Dabrowiak, F.T. Greenaway, W.E. Longo, M. vanHusen, and S.T. Crooke, Biochim. Biophys. Acta, 517, 517 (1978).
J.C. Dabrowiak, F.T. Greenaway, and R. Grulich, Biochemistry, 17, 4090(1978).
F.H. Fraser and D.J. Macero, Chem. Instrum.,4, 97 (1972).
J. Peisach and W.E. Blumburg, Arch. Biochem. Biophys., 165, 691 (1974).
J.C. Dabrowiak, W. E. Longo, and F.S. Santillo, unpublished results.
M. Konishi, K. Saito, K. Numata, T. Tsuno, K. Asama, H. Tsukiura, T. Naito, and H. Kawaguchi, J. Antibiot. (Tokyo), 30, 789 (1977).
G. Koyama, H. Nakamura, Y. Muraoka, T. Takita, K. Maeda, and H. Umezawa, Tetrahedron Lett., 44, 4635 (1968).
H. Asakura, M. Mori, and H. Umezawa, J. Antibiot. (Tokyo), 28, 537 (1975).
F.A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry, 3rd ed. Interscience Publishers New York, (1972).
E.J. Billa, Inorg. Nucl. Chern. Lett., 10, 613 (1974).
S.K. Gupta, T.S. Srivastava, J. Inorg. Nucl. Chem., 32, 1611 (1970).
H. Umezawa, Fed. Proc., 33, 2296 (1974).
H. Naganawa, Y. Muraoka, T. Takita, and H. Umezawa, J. Antibiot. (Tokyo), 30, 388 (1977).
T.F. Dorigatti and E.J. Billo, J. Inorg. Nucl. Chem., 37, 1515 (1975).
G.L. Eichhorn, Inorganic Biochemistry, Elsevier, New York (1973).
J.C. Dabrowiak and F.S. Santillo, unpublished results.
S. Koch, R.H. Holm, and R.B. Frankel, J. Am. Chern. Soc., 97, 6714 (1975).
B.R. McGarvey, Trans. Metal Chem., 3, 90 (1966).
W.E. Blumberg, In Magnetic Resonance in Biological Systems (A. Ehrenberg, B. E. Malmstrom, and T. Vanngard, Eds.), p.119. Pergamon Press, London (1967).
E.G. Janzen, D.E. Nutter, Jr., E.R. Davis, B.J. Blackburn, J.L. Poyer, and P.B. McCay, Can. J. Chem., 56, 2237 (19780).
J. Peisach and W.E. Blumberg, Adv. Chern. Ser., 100, 271 (1971).
S.G. Mairanovskii, J. Electroanal. Chem., 6, 77 (1963).
B. Janik and P.J. Elving, Chem. Rev., 68, 295 (1968).
D.L. Smith and P.J. Elving, J. Am. Chem. Soc., 84, 2741 (1962).
M. Chien, A.P. Grollman, and S.B. Horwitz, Biochemistry, 16, 364 (1977).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Dabrowiak, J., Greenway, F., Santillo, F. (1979). Erratum to: The Metallobleomycins. In: Hect, S.M. (eds) Bleomycin: Chemical, Biochemical, and Biological Aspects. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6191-9_31
Download citation
DOI: https://doi.org/10.1007/978-1-4612-6191-9_31
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-6193-3
Online ISBN: 978-1-4612-6191-9
eBook Packages: Springer Book Archive